VOTING
Your vote is important!
Please vote your proxy online now or by phone
by dialing 866-256-0714.
View an enhanced version of our Special Meeting Proxy Statement.
Your vote is important!
Please vote your proxy online now or by phone
by dialing 866-256-0714.
February 23, 2026
10:00 AM ET
At Avidity Biosciences, we are driven by our mission: to profoundly improve people’s lives by revolutionizing a new class of targeted RNA therapeutics. We are doing this by realizing the broad and disruptive potential of our Antibody Oligonucleotide Conjugates (AOC™) platform.
AOCs are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to target the root cause of diseases previously untreatable with RNA therapeutics.